Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD

Metabolic reprogramming is a key feature of Autosomal Dominant Polycystic Kidney Disease (ADPKD) characterized by changes in cellular pathways occurring in response to the pathological cell conditions. In ADPKD, a broad range of dysregulated pathways have been found. The studies supporting alteratio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roberto Pagliarini, Christine Podrini
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/ae76745dd9a24741b189a4bd188d2ce9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae76745dd9a24741b189a4bd188d2ce9
record_format dspace
spelling oai:doaj.org-article:ae76745dd9a24741b189a4bd188d2ce92021-11-30T17:56:24ZMetabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD2296-858X10.3389/fmed.2021.740087https://doaj.org/article/ae76745dd9a24741b189a4bd188d2ce92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.740087/fullhttps://doaj.org/toc/2296-858XMetabolic reprogramming is a key feature of Autosomal Dominant Polycystic Kidney Disease (ADPKD) characterized by changes in cellular pathways occurring in response to the pathological cell conditions. In ADPKD, a broad range of dysregulated pathways have been found. The studies supporting alterations in cell metabolism have shown that the metabolic preference for abnormal cystic growth is to utilize aerobic glycolysis, increasing glutamine uptake and reducing oxidative phosphorylation, consequently resulting in ADPKD cells shifting their energy to alternative energetic pathways. The mechanism behind the role of the polycystin proteins and how it leads to disease remains unclear, despite the identification of numerous signaling pathways. The integration of computational data analysis that accompanies experimental findings was pivotal in the identification of metabolic reprogramming in ADPKD. Here, we summarize the important results and argue that their exploitation may give further insights into the regulative mechanisms driving metabolic reprogramming in ADPKD. The aim of this review is to provide a comprehensive overview on metabolic focused studies and potential targets for treatment, and to propose that computational approaches could be instrumental in advancing this field of research.Roberto PagliariniChristine PodriniFrontiers Media S.A.articlemetabolismsystems biologysystems medicinetherapeuticsdrug repositioningADPKDMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic metabolism
systems biology
systems medicine
therapeutics
drug repositioning
ADPKD
Medicine (General)
R5-920
spellingShingle metabolism
systems biology
systems medicine
therapeutics
drug repositioning
ADPKD
Medicine (General)
R5-920
Roberto Pagliarini
Christine Podrini
Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
description Metabolic reprogramming is a key feature of Autosomal Dominant Polycystic Kidney Disease (ADPKD) characterized by changes in cellular pathways occurring in response to the pathological cell conditions. In ADPKD, a broad range of dysregulated pathways have been found. The studies supporting alterations in cell metabolism have shown that the metabolic preference for abnormal cystic growth is to utilize aerobic glycolysis, increasing glutamine uptake and reducing oxidative phosphorylation, consequently resulting in ADPKD cells shifting their energy to alternative energetic pathways. The mechanism behind the role of the polycystin proteins and how it leads to disease remains unclear, despite the identification of numerous signaling pathways. The integration of computational data analysis that accompanies experimental findings was pivotal in the identification of metabolic reprogramming in ADPKD. Here, we summarize the important results and argue that their exploitation may give further insights into the regulative mechanisms driving metabolic reprogramming in ADPKD. The aim of this review is to provide a comprehensive overview on metabolic focused studies and potential targets for treatment, and to propose that computational approaches could be instrumental in advancing this field of research.
format article
author Roberto Pagliarini
Christine Podrini
author_facet Roberto Pagliarini
Christine Podrini
author_sort Roberto Pagliarini
title Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
title_short Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
title_full Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
title_fullStr Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
title_full_unstemmed Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
title_sort metabolic reprogramming and reconstruction: integration of experimental and computational studies to set the path forward in adpkd
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/ae76745dd9a24741b189a4bd188d2ce9
work_keys_str_mv AT robertopagliarini metabolicreprogrammingandreconstructionintegrationofexperimentalandcomputationalstudiestosetthepathforwardinadpkd
AT christinepodrini metabolicreprogrammingandreconstructionintegrationofexperimentalandcomputationalstudiestosetthepathforwardinadpkd
_version_ 1718406402002649088